Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Tobias Alexander

Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Riccardo Saccardi

Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST)

Non-interventional Prospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Riccardo Saccardi

Outcomes of HSCT for autoimmune cytopenias (AIC): a Retrospective Registry Study from the Autoimmune Diseases Working Party (ADWP) and the Paediatric Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Allogenic Hematopoietic Stem Cell Transplantation for Adult Sickle Cell Disease: A registry study on behalf of the EBMT Pediatric Disease Working Party

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Outcomes of allogeneic stem cell transplantation in paediatric patients affected with autosomal dominant RUNX1 mutation related disease

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini

Treo Flu vs Bu Flu +/-Thio in SCD from 2010-2014 (extended to 2017), part of first Medac Study

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Outcome of children developing grade III-IV aGVHD after allogeneic HSCT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Giovanna Lucchini

Pronostic des enfants développant une GvHD aiguë de grade III-IV après une greffe allogénique de cellules souches hématopoïétiques

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Giovanna Lucchini

Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Type de traitement

Investigateur principal

HSCT for Congenital Amegakaryocitic thrombopecytopenia (CAMT)

Closed Survey/Study

Bone marrow failure

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Clémence Aldebert

Greffe de cellules souches hématopoïétiques (HSCT) pour la thrombocytopénie amégacaryocytaire congénitale (CAMT)

Aplasie Médullaire

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Clémence Aldebert